Literature DB >> 32298918

Correlation between atmospheric particulate matter and antibiotic resistance: A hypothesis.

Emanuele Rizzo1, Giuseppe Maggiotto2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32298918      PMCID: PMC7138388          DOI: 10.1016/j.mehy.2020.109706

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


× No keyword cloud information.
Dear Editors, the Italian National Health System, universally recognized as one of the best in the world also by recent studies [1], has faced two important health threats in recent years, in addition to the current SARS-CoV-2 epidemic: Italy is in first place in Europe both for premature deaths due to exposure to PM2.5 fine particulate matter (58,600 deaths in 2016) [2] and for the number of deaths due to infections caused by antibiotic-resistant bacteria (over 10,700 in 2015, 1/3 out of the total of the European Union) [3], with the latter data confirmed not only by the high quantity of prescriptions of these drugs for medical use [4], but also and above all by the large percentage of sales for veterinary applications and zootechnics [5]. Therefore, a question arises: could there be a connection between these two apparently so different phenomena? Indeed, a hypothesis could be advanced, moving from the epidemiological data to a biochemical explanation. PM2.5 or lower particles could adsorb fragments of nuclear or plasmid DNA [6] from the environmental resistome or from bacteria (not only pathogenic) that are dead but resistant or multiresistant (both environmental and hospital), therefore containing Antibiotic Resistance Genes (ARGs), and disseminate them everywhere through the wind or other atmospheric manifestations. These DNA fragments could later penetrate, using PM2.5 or lower particles as carriers (also biocompatible), into other bacteria (also of different genres) which could exploit them evolutionarily to obtain new characteristics of resistance, integrating these genes in their nuclear genome or in their plasmids (therefore transferring them to other germs by conjugation, a mode already favored by PM2.5 particles [7]) with a mechanism similar to bacterial transformation or biolistic method, widely used in research laboratories. In this way, high concentrations of atmospheric particulate matter, already a cause of death in itself, could passively and actively favor the propagation of the phenomenon of antibiotic resistance, with its burden of disease. With this in mind, health costs of air pollution should be reviewed, also adding the possible share of costs due to hospitalizations for infectious diseases from antibiotic-resistant germs.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
  4 in total

1.  The effect and mechanism of urban fine particulate matter (PM2.5) on horizontal transfer of plasmid-mediated antimicrobial resistance genes.

Authors:  Shanshan Xie; April Z Gu; Tianyu Cen; Dan Li; Jianmin Chen
Journal:  Sci Total Environ       Date:  2019-05-09       Impact factor: 7.963

2.  Antibiotics, bacteria, and antibiotic resistance genes: aerial transport from cattle feed yards via particulate matter.

Authors:  Andrew D McEachran; Brett R Blackwell; J Delton Hanson; Kimberly J Wooten; Gregory D Mayer; Stephen B Cox; Philip N Smith
Journal:  Environ Health Perspect       Date:  2015-01-22       Impact factor: 9.031

3.  Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis.

Authors:  Alessandro Cassini; Liselotte Diaz Högberg; Diamantis Plachouras; Annalisa Quattrocchi; Ana Hoxha; Gunnar Skov Simonsen; Mélanie Colomb-Cotinat; Mirjam E Kretzschmar; Brecht Devleesschauwer; Michele Cecchini; Driss Ait Ouakrim; Tiago Cravo Oliveira; Marc J Struelens; Carl Suetens; Dominique L Monnet
Journal:  Lancet Infect Dis       Date:  2018-11-05       Impact factor: 25.071

4.  Italy's health performance, 1990-2017: findings from the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet Public Health       Date:  2019-11-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.